These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21057402)

  • 1. Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
    Agius M; Gardner J; Liu K; Zaman R
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S46-8. PubMed ID: 21057402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
    Agius M; Gardner J; Liu K; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):350-3. PubMed ID: 20562780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
    Agius M; Gardner J; Liu K; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):346-9. PubMed ID: 20562779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
    Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An audit to compare the efficacy of treatment (as indicated by discharge rates and reduction in suicidality) among patients with refractory depression in a Bedfordshire Community Mental Health Team receiving augmentation therapy with either mirtazepine or atypical antipsychotics.
    Butler S; Holt C; Agius M; Zaman R
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S171-4. PubMed ID: 21894129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant switching among adherent patients treated for depression.
    Marcus SC; Hassan M; Olfson M
    Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicide risk and choice of antidepressant.
    Davis A; Gilhooley M; Agius M; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):358-9. PubMed ID: 20562782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of early onset of antidepressant effect in randomized controlled trials.
    Stahl SM; Nierenberg AA; Gorman JM
    J Clin Psychiatry; 2001; 62 Suppl 4():17-23; discussion 37-40. PubMed ID: 11229783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
    Banerjee S; Hellier J; Romeo R; Dewey M; Knapp M; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A
    Health Technol Assess; 2013 Feb; 17(7):1-166. PubMed ID: 23438937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in the Pharmacotherapy of Adolescent Depression.
    Masi G
    Curr Pharm Des; 2022; 28(24):1975-1984. PubMed ID: 35619257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
    Egberts AC; Lenderink AW; de Koning FH; Leufkens HG
    J Clin Psychopharmacol; 1997 Jun; 17(3):149-55. PubMed ID: 9169957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the clinical efficacy of mirtazapine.
    Benkert O; Muller M; Szegedi A
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
    Banerjee S; Hellier J; Dewey M; Romeo R; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Knapp M; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A
    Lancet; 2011 Jul; 378(9789):403-11. PubMed ID: 21764118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
    Gourion D
    Encephale; 2008 Jan; 34(1):73-81. PubMed ID: 18514154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New formulations of existing antidepressants: advantages in the management of depression.
    Norman TR; Olver JS
    CNS Drugs; 2004; 18(8):505-20. PubMed ID: 15182220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.